Statistics for Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV. patients: The MALACHITE-I/II. trials.
Total visits
| views | |
|---|---|
| Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV. patients: The MALACHITE-I/II. trials. | 59 |
Total visits per month
| views | |
|---|---|
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
File Visits
| views | |
|---|---|
| Efficacy and safety of ombitasvir-paritaprevir-r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients, The MALACHITE-I-II trials..pdf | 72 |
Top country views
| views | |
|---|---|
| United States | 38 |
| Chile | 11 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 36 |
| Santiago | 10 |
| Campbell | 1 |
| Punta Arenas | 1 |
| Sacramento | 1 |
| Zapopan | 1 |